24/09/2026
FMC Abuja Strengthens Prostate Cancer Care with Launch of Dedicated MDT
_Multidisciplinary team brings together specialists to advance coordinated, patient-centred cancer management under at FMC Abuja_
The Federal Medical Centre Abuja has taken another significant step towards strengthening cancer care with the launch of a dedicated Prostate Cancer Multidisciplinary Team (MDT), aimed at promoting coordinated, evidence-informed and patient-centred management of men living with prostate cancer.
The initiative was unveiled during the September Physical Multidisciplinary Team Meeting organised by the Multidisciplinary Cancer Committee of FMC Abuja in collaboration with Janssen & Johnson (J&J) Pharmaceuticals.
The meeting brought together specialists and healthcare professionals across relevant disciplines, providing a platform for shared clinical expertise, collaborative decision-making and improved coordination of cancer services.
Among those present were the Head of Clinical Services, Dr Bioku Muftau; Head of the Urology Unit, Dr Kene; Chairman, Multidisciplinary Cancer Committee, Dr Tessy Ahmadu; Clinical Oncologist, Dr Popoola; Urologist, Dr Lovely; Gynaecologist, Dr Almustapha; resident doctors from Oncology, Urology, Pathology and Gynaecology, as well as oncology nurses, pharmacists and other members of the multidisciplinary cancer care team.
The launch of the Prostate Cancer MDT represents an important development in the Centre's continuing efforts to establish more structured and integrated pathways for cancer care.
Through the dedicated team, specialists from different disciplines will have a common platform to contribute their expertise to the diagnosis, staging, treatment planning and follow-up of patients with prostate cancer, while supporting timely referrals and continuity of care.
The development is also consistent with the broader healthcare vision of the Medical Director, FMC Abuja, Prof. Saad Ahmed, whose administration has continued to emphasise quality healthcare delivery, professional collaboration, specialised services, research and patient-centred care.
Under this approach, multidisciplinary collaboration remains an important component of efforts to strengthen the Centre's capacity to provide comprehensive cancer services and improve access to specialised care for Nigerians.
The September MDT meeting further reinforced the importance of bringing different professional perspectives together in the management of complex cancer cases. Rather than working in isolation, specialists are able to deliberate collectively on patient management, ensuring that relevant clinical considerations are incorporated into treatment decisions.
The initiative also provides an avenue for continuous professional learning and knowledge-sharing among consultants, resident doctors, nurses, pharmacists and other healthcare professionals involved in cancer management.
Speaking through the activities of the committee, the Centre reaffirmed its commitment to building stronger multidisciplinary structures that can support efficient, coordinated and compassionate cancer care.
The collaboration with J&J Pharmaceuticals was equally acknowledged as part of the collective effort to strengthen cancer-care initiatives and support professional engagement around improved patient management.
With the activation of the Prostate Cancer MDT, FMC Abuja is further positioning its cancer services around collaboration, expertise and coordinated patient care.
The initiative re-emphasis the Centre's continuing commitment to its core responsibility of Service to Humanity, while advancing its mission of providing quality, specialised and patient-focused healthcare.
At FMC Abuja, the message is clear: stronger teamwork can translate into stronger cancer services and ultimately better care for patients.
SIGNED
Obadiah N.K Gana
Public Relations Officer